{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T05:26:16Z","timestamp":1790745976159,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,2,10]],"date-time":"2015-02-10T00:00:00Z","timestamp":1423526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"},{"start":{"date-parts":[[2015,2,10]],"date-time":"2015-02-10T00:00:00Z","timestamp":1423526400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Res"],"DOI":"10.1038\/boneres.2014.42","type":"journal-article","created":{"date-parts":[[2015,2,10]],"date-time":"2015-02-10T10:09:41Z","timestamp":1423562981000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":53,"title":["Administration of soluble activin receptor 2B increases bone and muscle mass in a mouse model of osteogenesis imperfecta"],"prefix":"10.1038","volume":"3","author":[{"given":"Douglas J.","family":"DiGirolamo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vandana","family":"Singhal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Se-Jin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily L.","family":"Germain-Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,2,10]]},"reference":[{"key":"BFboneres201442_CR1","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s00223-012-9588-3","volume":"90","author":"T Cundy","year":"2012","unstructured":"Cundy T . Recent advances in osteogenesis imperfecta. Calcif Tissue Int 2012; 90: 439\u2013449.","journal-title":"Calcif Tissue Int"},{"key":"BFboneres201442_CR2","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1007\/s00223-013-9723-9","volume":"93","author":"DR Eyre","year":"2013","unstructured":"Eyre DR, Weis MA . Bone collagen: new clues to its mineralization mechanism from recessive osteogenesis imperfecta. Calcif Tissue Int 2013; 93: 338\u2013347.","journal-title":"Calcif Tissue Int"},{"key":"BFboneres201442_CR3","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1136\/jmg.16.2.101","volume":"16","author":"DO Sillence","year":"1979","unstructured":"Sillence DO, Senn A, Danks DM . Genetic heterogeneity in osteogenesis imperfecta. J Med Genet 1979; 16: 101\u2013116.","journal-title":"J Med Genet"},{"key":"BFboneres201442_CR4","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/B978-0-12-397165-4.00001-0","volume-title":"Osteogenesis Imperfecta","author":"DO Sillence","year":"2014","unstructured":"Sillence DO, Lamande SR . Evolution of the present understanding of the clinical and genetic heterogeneity and molecular and biochemical basis of osteogenesis imperfecta. In: Shapiro J, Byers P, Glorieux F, Sponseller P (ed.), Osteogenesis Imperfecta. New York: Elsevier Academic Press 2014: 5\u201314."},{"key":"BFboneres201442_CR5","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1007\/s00431-006-0083-6","volume":"165","author":"AM Boot","year":"2006","unstructured":"Boot AM, de Coo RF, Pals G, de Muinck Keizer-Schrama SM . Muscle weakness as presenting symptom of osteogenesis imperfecta. Eur J Pediatr 2006; 165: 392\u2013394.","journal-title":"Eur J Pediatr"},{"key":"BFboneres201442_CR6","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1097\/PEP.0b013e3181ea8b8d","volume":"22","author":"A Caudill","year":"2010","unstructured":"Caudill A, Flanagan A, Hassani S et al. Ankle strength and functional limitations in children and adolescents with type I osteogenesis imperfecta. Pediatr Phys Ther 2010; 22: 288\u2013295.","journal-title":"Pediatr Phys Ther"},{"key":"BFboneres201442_CR7","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/j.jpeds.2004.08.003","volume":"145","author":"T Takken","year":"2004","unstructured":"Takken T, Terlingen HC, Helders PJ, Pruijs H, van der Ent CK, Engelbert RH . Cardiopulmonary fitness and muscle strength in patients with osteogenesis imperfecta type I. J Pediatr 2004; 145: 813\u2013818.","journal-title":"J Pediatr"},{"key":"BFboneres201442_CR8","doi-asserted-by":"publisher","first-page":"E356","DOI":"10.1210\/jc.2013-3209","volume":"99","author":"LN Veilleux","year":"2014","unstructured":"Veilleux LN, Lemay M, Pouliot-Laforte A, Cheung MS, Glorieux FH, Rauch F . Muscle anatomy and dynamic muscle function in osteogenesis imperfecta type I. J Clin Endocrinol Metab 2014; 99: E356\u2013E362.","journal-title":"J Clin Endocrinol Metab"},{"key":"BFboneres201442_CR9","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1097\/PEP.0000000000000042","volume":"26","author":"E Brizola","year":"2014","unstructured":"Brizola E, Staub AL, Felix TM . Muscle strength, joint range of motion, and gait in children and adolescents with osteogenesis imperfecta. Pediatr Phys Ther 2014; 26: 245\u2013252.","journal-title":"Pediatr Phys Ther"},{"key":"BFboneres201442_CR10","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/387083a0","volume":"387","author":"AC McPherron","year":"1997","unstructured":"McPherron AC, Lawler AM, Lee SJ . Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature 1997; 387: 83\u201390.","journal-title":"Nature"},{"key":"BFboneres201442_CR11","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.exger.2012.11.004","volume":"48","author":"M Bowser","year":"2013","unstructured":"Bowser M, Herberg S, Arounleut P et al. Effects of the activin A-myostatin-follistatin system on aging bone and muscle progenitor cells. Exp Gerontol 2013; 48: 290\u2013297.","journal-title":"Exp Gerontol"},{"key":"BFboneres201442_CR12","unstructured":"Digirolamo D, Singhal V, Clemens T, Lee SJ . Systemic administration of soluble 483 activin receptors produces differential anabolic effects in muscle and bone in mice. J Bone Miner Res 2011; 26 (Suppl 1)."},{"key":"BFboneres201442_CR13","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1002\/ar.a.10044","volume":"272","author":"MW Hamrick","year":"2003","unstructured":"Hamrick MW . Increased bone mineral density in the femora of GDF8 knockout mice. Anat Rec A Discov Mol Cell Evol Biol 2003; 272: 388\u2013391.","journal-title":"Anat Rec A Discov Mol Cell Evol Biol"},{"key":"BFboneres201442_CR14","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.bone.2008.08.126","volume":"44","author":"E Kellum","year":"2009","unstructured":"Kellum E, Starr H, Arounleut P et al. Myostatin (GDF-8) deficiency increases fracture callus size, Sox-5 expression, and callus bone volume. Bone 2009; 44: 17\u201323.","journal-title":"Bone"},{"key":"BFboneres201442_CR15","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s00198-007-0435-8","volume":"19","author":"ZL Zhang","year":"2008","unstructured":"Zhang ZL, He JW, Qin YJ et al. Association between myostatin gene polymorphisms and peak BMD variation in Chinese nuclear families. Osteoporos Int. 2008; 19: 39\u201347.","journal-title":"Osteoporos Int"},{"key":"BFboneres201442_CR16","doi-asserted-by":"publisher","first-page":"4289","DOI":"10.1210\/en.2010-0134","volume":"151","author":"A Koncarevic","year":"2010","unstructured":"Koncarevic A, Cornwall-Brady M, Pullen A et al. A soluble activin receptor type IIb prevents the effects of androgen deprivation on body composition and bone health. Endocrinology 2010; 151: 4289\u20134300.","journal-title":"Endocrinology"},{"key":"BFboneres201442_CR17","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1038\/nature01154","volume":"420","author":"S Bogdanovich","year":"2002","unstructured":"Bogdanovich S, Krag TO, Barton ER et al. Functional improvement of dystrophic muscle by myostatin blockade. Nature 2002; 420: 418\u2013421.","journal-title":"Nature"},{"key":"BFboneres201442_CR18","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.cell.2010.07.011","volume":"142","author":"X Zhou","year":"2010","unstructured":"Zhou X, Wang JL, Lu J et al. Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival. Cell 2010; 142: 531\u2013543.","journal-title":"Cell"},{"key":"BFboneres201442_CR19","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1093\/gerona\/glt030","volume":"68","author":"CS Chiu","year":"2013","unstructured":"Chiu CS, Peekhaus N, Weber H et al. Increased muscle force production and bone mineral density in ActRIIB-Fc-treated mature rodents. J Gerontol A Biol Sci Med Sci 2013; 68: 1181\u20131192.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"BFboneres201442_CR20","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1002\/jbmr.1969","volume":"28","author":"DJ DiGirolamo","year":"2013","unstructured":"DiGirolamo DJ, Kiel DP, Esser KA . Bone and skeletal muscle: neighbors with close ties. J Bone Miner Res 2013; 28: 1509\u20131518.","journal-title":"J Bone Miner Res"},{"key":"BFboneres201442_CR21","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.matbio.2010.06.006","volume":"29","author":"BA Gentry","year":"2010","unstructured":"Gentry BA, Ferreira JA, McCambridge AJ, Brown M, Phillips CL . Skeletal muscle weakness in osteogenesis imperfecta mice. Matrix Biol 2010; 29: 638\u2013644.","journal-title":"Matrix Biol"},{"key":"BFboneres201442_CR22","doi-asserted-by":"publisher","first-page":"18117","DOI":"10.1073\/pnas.0505996102","volume":"102","author":"SJ Lee","year":"2005","unstructured":"Lee SJ, Reed LA, Davies MV et al. Regulation of muscle growth by multiple ligands signaling through activin type II receptors. Proc Natl Acad Sci USA 2005; 102: 18117\u201318122.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFboneres201442_CR23","doi-asserted-by":"publisher","first-page":"1468","DOI":"10.1002\/jbmr.141","volume":"25","author":"ML Bouxsein","year":"2010","unstructured":"Bouxsein ML, Boyd SK, Christiansen BA, Guldberg RE, Jepsen KJ, Muller R . Guidelines for assessment of bone microstructure in rodents using micro-computed tomography. J Bone Miner Res 2010; 25: 1468\u20131486.","journal-title":"J Bone Miner Res"},{"key":"BFboneres201442_CR24","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1002\/jbmr.1805","volume":"28","author":"DW Dempster","year":"2013","unstructured":"Dempster DW, Compston JE, Drezner MK et al. Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 2013; 28: 2\u201317.","journal-title":"J Bone Miner Res"},{"key":"BFboneres201442_CR25","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1007\/BF00350961","volume":"16","author":"JP Devogelaer","year":"1987","unstructured":"Devogelaer JP, Malghem J, Maldague B, Nagant de Deuxchaisnes C . Radiological manifestations of bisphosphonate treatment with APD in a child suffering from osteogenesis imperfecta. Skeletal Radiol 1987; 16: 360\u2013363.","journal-title":"Skeletal Radiol"},{"key":"BFboneres201442_CR26","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1016\/S0140-6736(04)16051-0","volume":"363","author":"F Rauch","year":"2004","unstructured":"Rauch F, Glorieux FH . Osteogenesis imperfecta. Lancet 2004; 363: 1377\u20131385.","journal-title":"Lancet"},{"key":"BFboneres201442_CR27","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1359\/JBMR.051207","volume":"21","author":"C Land","year":"2006","unstructured":"Land C, Rauch F, Glorieux FH . Cyclical intravenous pamidronate treatment affects metaphyseal modeling in growing patients with osteogenesis imperfecta. J Bone Miner Res 2006; 21: 374\u2013379.","journal-title":"J Bone Miner Res"},{"key":"BFboneres201442_CR28","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.bone.2006.11.020","volume":"40","author":"F Rauch","year":"2007","unstructured":"Rauch F, Cornibert S, Cheung M, Glorieux FH . Long-bone changes after pamidronate discontinuation in children and adolescents with osteogenesis imperfecta. Bone 2007; 40: 821\u2013827.","journal-title":"Bone"},{"key":"BFboneres201442_CR29","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1359\/JBMR.040814","volume":"19","author":"CF Munns","year":"2004","unstructured":"Munns CF, Rauch F, Zeitlin L, Fassier F, Glorieux FH . Delayed osteotomy but not fracture healing in pediatric osteogenesis imperfecta patients receiving pamidronate. J Bone Miner Res 2004; 19: 1779\u20131786.","journal-title":"J Bone Miner Res"},{"key":"BFboneres201442_CR30","first-page":"77","volume":"12","author":"L Zeitlin","year":"2003","unstructured":"Zeitlin L, Fassier F, Glorieux FH . Modern approach to children with osteogenesis imperfecta. J Pediatr Orthop B 2003; 12: 77\u201387.","journal-title":"J Pediatr Orthop B"},{"key":"BFboneres201442_CR31","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.bone.2013.12.002","volume":"60","author":"P Bialek","year":"2014","unstructured":"Bialek P, Parkington J, Li X et al. A myostatin and activin decoy receptor enhances bone formation in mice. Bone 2014; 60: 162\u2013171.","journal-title":"Bone"},{"key":"BFboneres201442_CR32","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.bone.2009.09.018","volume":"46","author":"RJ Fajardo","year":"2010","unstructured":"Fajardo RJ, Manoharan RK, Pearsall RS et al. Treatment with a soluble receptor for activin improves bone mass and structure in the axial and appendicular skeleton of female cynomolgus macaques (Macaca fascicularis). Bone 2010; 46: 64\u201371.","journal-title":"Bone"},{"key":"BFboneres201442_CR33","doi-asserted-by":"publisher","first-page":"7082","DOI":"10.1073\/pnas.0711263105","volume":"105","author":"RS Pearsall","year":"2008","unstructured":"Pearsall RS, Canalis E, Cornwall-Brady M et al. A soluble activin type IIA receptor induces bone formation and improves skeletal integrity. Proc Natl Acad Sci USA 2008; 105: 7082\u20137087.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFboneres201442_CR34","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1210\/me.2011-1168","volume":"26","author":"S Kokabu","year":"2012","unstructured":"Kokabu S, Gamer L, Cox K et al. BMP3 suppresses osteoblast differentiation of bone marrow stromal cells via interaction with Acvr2b. Mol Endocrinol 2012; 26: 87\u201394.","journal-title":"Mol Endocrinol"}],"container-title":["Bone Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/boneres201442.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/boneres201442","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/boneres201442.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T10:07:48Z","timestamp":1672913268000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/boneres201442"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,10]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,12,22]]}},"alternative-id":["BFboneres201442"],"URL":"https:\/\/doi.org\/10.1038\/boneres.2014.42","relation":{},"ISSN":["2095-6231"],"issn-type":[{"value":"2095-6231","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,10]]},"assertion":[{"value":"24 October 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2014","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2014","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2015","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14042"}}